company background image
NORDH logo

Nordhealth OB:NORDH Stock Report

Last Price

NOK 39.80

Market Cap

NOK 3.1b

7D

-1.7%

1Y

76.1%

Updated

23 Dec, 2024

Data

Company Financials +

NORDH Stock Overview

Provides healthcare software solutions in Norway, Finland, Sweden, Denmark, Germany, and internationally. More details

NORDH fundamental analysis
Snowflake Score
Valuation0/6
Future Growth4/6
Past Performance0/6
Financial Health6/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

Nordhealth AS Competitors

Price History & Performance

Summary of share price highs, lows and changes for Nordhealth
Historical stock prices
Current Share PriceNOK 39.80
52 Week HighNOK 45.80
52 Week LowNOK 21.30
Beta0.51
1 Month Change6.13%
3 Month Change6.13%
1 Year Change76.11%
3 Year Change8.65%
5 Year Changen/a
Change since IPO7.57%

Recent News & Updates

We're Not Very Worried About Nordhealth's (OB:NORDH) Cash Burn Rate

Sep 28
We're Not Very Worried About Nordhealth's (OB:NORDH) Cash Burn Rate

Recent updates

We're Not Very Worried About Nordhealth's (OB:NORDH) Cash Burn Rate

Sep 28
We're Not Very Worried About Nordhealth's (OB:NORDH) Cash Burn Rate

Here's Why We're Not Too Worried About Nordhealth's (OB:NORDH) Cash Burn Situation

May 10
Here's Why We're Not Too Worried About Nordhealth's (OB:NORDH) Cash Burn Situation

Nordhealth AS' (OB:NORDH) 25% Jump Shows Its Popularity With Investors

Apr 10
Nordhealth AS' (OB:NORDH) 25% Jump Shows Its Popularity With Investors

What You Can Learn From Nordhealth AS' (OB:NORDH) P/S

Feb 23
What You Can Learn From Nordhealth AS' (OB:NORDH) P/S

Nordhealth (OB:NORDH) Is In A Good Position To Deliver On Growth Plans

Jan 03
Nordhealth (OB:NORDH) Is In A Good Position To Deliver On Growth Plans

Getting In Cheap On Nordhealth AS (OB:NORDH) Might Be Difficult

May 12
Getting In Cheap On Nordhealth AS (OB:NORDH) Might Be Difficult

Estimating The Intrinsic Value Of Nordhealth AS (OB:NORDH)

Jan 25
Estimating The Intrinsic Value Of Nordhealth AS (OB:NORDH)

Shareholder Returns

NORDHNO Healthcare ServicesNO Market
7D-1.7%0.6%-1.8%
1Y76.1%11.1%-0.8%

Return vs Industry: NORDH exceeded the Norwegian Healthcare Services industry which returned 11.1% over the past year.

Return vs Market: NORDH exceeded the Norwegian Market which returned -0.8% over the past year.

Price Volatility

Is NORDH's price volatile compared to industry and market?
NORDH volatility
NORDH Average Weekly Movement10.4%
Healthcare Services Industry Average Movement6.0%
Market Average Movement5.0%
10% most volatile stocks in NO Market11.0%
10% least volatile stocks in NO Market2.6%

Stable Share Price: NORDH's share price has been volatile over the past 3 months compared to the Norwegian market.

Volatility Over Time: NORDH's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of Norwegian stocks.

About the Company

FoundedEmployeesCEOWebsite
2001403Charles MacBainnordhealth.com

Nordhealth AS provides healthcare software solutions in Norway, Finland, Sweden, Denmark, Germany, and internationally. Its products include Provet Cloud, a veterinary practice management software (PMS); Diarium, a PMS for therapists that streamlines therapy sessions, booking, and invoicing; Physica, a PMS for physiotherapists; Psykbase, a PMS for psychologists and psychotherapists; EasyPractice, a PMS for therapists; and various PMS for veterinarians under the Provet Net, Vetserve, Sanimalis, Vetvision, and Vetera names. The company’s products also comprise Nordhealth Connect, a communication platform for patients and healthcare professionals; and Navisec, a digital learning environment for training and orientation.

Nordhealth AS Fundamentals Summary

How do Nordhealth's earnings and revenue compare to its market cap?
NORDH fundamental statistics
Market capNOK 3.15b
Earnings (TTM)-NOK 97.67m
Revenue (TTM)NOK 516.45m

6.1x

P/S Ratio

-32.2x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
NORDH income statement (TTM)
Revenue€43.69m
Cost of Revenue€30.24m
Gross Profit€13.45m
Other Expenses€21.71m
Earnings-€8.26m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

Mar 04, 2025

Earnings per share (EPS)-0.10
Gross Margin30.78%
Net Profit Margin-18.91%
Debt/Equity Ratio0%

How did NORDH perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 23:01
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Nordhealth AS is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kristian StøleCarnegie Investment Bank AB